Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2020 | 3 |
2023 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and challenges.
Cancer Lett. 2020 Aug 28;486:29-37. doi: 10.1016/j.canlet.2020.05.020. Epub 2020 May 22.
Cancer Lett. 2020.
PMID: 32446861
Free article.
Review.
Hyperactivation of nuclear receptor coactivators induces PERK-dependent cell death.
Hossain MM, Barua D, Arabkari V, Islam N, Gupta A, Gupta S.
Hossain MM, et al. Among authors: barua d.
Oncotarget. 2018 Feb 8;9(14):11707-11721. doi: 10.18632/oncotarget.24451. eCollection 2018 Feb 20.
Oncotarget. 2018.
PMID: 29545931
Free PMC article.
Item in Clipboard
UPR-Induced miR-616 Inhibits Human Breast Cancer Cell Growth and Migration by Targeting c-MYC.
Arabkari V, Sultana A, Barua D, Webber M, Smith T, Gupta A, Gupta S.
Arabkari V, et al. Among authors: barua d.
Int J Mol Sci. 2023 Aug 22;24(17):13034. doi: 10.3390/ijms241713034.
Int J Mol Sci. 2023.
PMID: 37685841
Free PMC article.
Item in Clipboard
Differential expression, function and prognostic value of miR-17-92 cluster in ER-positive and triple-negative breast cancer.
Hossain MM, Sultana A, Barua D, Islam MN, Gupta A, Gupta S.
Hossain MM, et al. Among authors: barua d.
Cancer Treat Res Commun. 2020;25:100224. doi: 10.1016/j.ctarc.2020.100224. Epub 2020 Oct 17.
Cancer Treat Res Commun. 2020.
PMID: 33096318
Free article.
Item in Clipboard
RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity.
Barua D, Sultana A, Islam MN, Cox F, Gupta A, Gupta S.
Barua D, et al.
BMC Cancer. 2023 Mar 30;23(1):288. doi: 10.1186/s12885-023-10745-1.
BMC Cancer. 2023.
PMID: 36997866
Free PMC article.
Item in Clipboard
XBP1 increases transactivation of somatic mutants of ESR1 and loss of XBP1 reverses endocrine resistance conferred by gain-of-function Y537S ESR1 mutation.
Barua D, Abbasi B, Gupta A, Gupta S.
Barua D, et al.
Heliyon. 2020 Oct 10;6(10):e05217. doi: 10.1016/j.heliyon.2020.e05217. eCollection 2020 Oct.
Heliyon. 2020.
PMID: 33088967
Free PMC article.
Item in Clipboard
miRNA-378 Is Downregulated by XBP1 and Inhibits Growth and Migration of Luminal Breast Cancer Cells.
Arabkari V, Barua D, Hossain MM, Webber M, Smith T, Gupta A, Gupta S.
Arabkari V, et al. Among authors: barua d.
Int J Mol Sci. 2023 Dec 22;25(1):186. doi: 10.3390/ijms25010186.
Int J Mol Sci. 2023.
PMID: 38203358
Free PMC article.
Item in Clipboard
Cite
Cite